197 results on '"P. Brisou"'
Search Results
2. Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma
- Author
-
Pierre Sesques, Amy A. Kirkwood, Mi Kwon, Kai Rejeski, Michael D. Jain, Roberta Di Blasi, Gabriel Brisou, François-Xavier Gros, Fabien le Bras, Pierre Bories, Sylvain Choquet, Marie-Thérèse Rubio, Gloria Iacoboni, Maeve O’Reilly, René-Olivier Casasnovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Julie Abraham, Cristina Castilla Llorente, Mickael Loschi, Sylvain Carras, Adrien Chauchet, Laurianne Drieu La Rochelle, Olivier Hermine, Stéphanie Guidez, Pascale Cony-Makhoul, Patrick Fogarty, Steven Le Gouill, Franck Morschhauser, Thomas Gastinne, Guillaume Cartron, Marion Subklewe, Frederick L. Locke, Robin Sanderson, Pere Barba, Roch Houot, and Emmanuel Bachy
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Autologous anti-CD19 chimeric antigen receptor (CAR) T cells are now used in routine practice for relapsed/refractory (R/R) large B-cell lymphoma (LBCL). Severe (grade ≥ 3) cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity (ICANS) are still the most concerning acute toxicities leading to frequent intensive care unit (ICU) admission, prolonging hospitalization, and adding significant cost to treatment. We report on the incidence of CRS and ICANS and the outcomes in a large cohort of 925 patients with LBCL treated with axicabtagene ciloleucel (axi-cel) or tisagenlecleucel (tisa-cel) in France based on patient data captured through the DESCAR-T registry. CRS of any grade occurred in 778 patients (84.1%), with 74 patients (8.0%) with grade 3 CRS or higher, while ICANS of any grade occurred in 375 patients (40.5%), with 112 patients (12.1%) with grade ≥ 3 ICANS. Based on the parameters selected by multivariable analyses, two independent prognostic scoring systems (PSS) were derived, one for grade ≥ 3 CRS and one for grade ≥ 3 ICANS. CRS-PSS included bulky disease, a platelet count 30 mg/L and no bridging therapy or stable or progressive disease (SD/PD) after bridging. Patients with a CRS-PSS score > 2 had significantly higher risk to develop grade ≥ 3 CRS. ICANS-PSS included female sex, low level of platelets ( 2 had significantly higher risk to develop grade ≥ 3 ICANS. Both scores were externally validated in international cohorts of patients treated with tisa-cel or axi-cel.
- Published
- 2024
- Full Text
- View/download PDF
3. Comorbidity burden on mortality in patients with systemic sclerosis
- Author
-
Thomas Barnetche, Marie-Elise Truchetet, Pierre Duffau, Julien Seneschal, Estibaliz Lazaro, Thomas Fauthoux, Cécile Contin-Bordes, Elodie Blanchard, Joel Constans, Damien Brisou, and Sophie Skopinski
- Subjects
Medicine - Abstract
Introduction Systemic sclerosis (SSc) is a serious life-threatening tissue disease. A significant aspect of its mortality arises from comorbid conditions. Our study aimed at mapping out the prevalence of these comorbidities and their relation to mortality, thus creating a ‘comorbidome’.Methods In our retrospective, single-centre observational study, we recorded each patient’s data, including demographic informations, vital stats and SSc-related organ involvement, along with the presence or absence of 14 predefined comorbidities. We also documented the dates of their initial and most recent visits. To construct survival curves, we used the Kaplan-Meier method, followed by a Cox regression model for multivariate analysis.Results Our study involved 400 participants, 74 of whom unfortunately passed away. It is important to note that three specific comorbidities showed significant correlation to mortality: neoplasia, cardiovascular diseases and polypharmacy, as well as two SSc-specific organ involvements (lung and cardiac).Conclusion Our research led to the successful creation of the SSc comorbidome. Comorbidities are a major concern for patients suffering from SSc, particularly cardiovascular diseases and neoplasms. Our study highlights the effects of polypharmacy. The resultant comorbidome offers a comprehensive and analytical perspective on this complex issue and underscores the inter-relatedness of the data. Our study, however, was limited by a small sample size. Therefore, to confirm our findings, validation on a larger scale is necessary. This could potentially contribute to the creation of a future mortality scoring tool.
- Published
- 2024
- Full Text
- View/download PDF
4. Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
- Author
-
Houot, Roch, Bachy, Emmanuel, Cartron, Guillaume, Gros, François-Xavier, Morschhauser, Franck, Oberic, Lucie, Gastinne, Thomas, Feugier, Pierre, Duléry, Rémy, Thieblemont, Catherine, Joris, Magalie, Jardin, Fabrice, Choquet, Sylvain, Casasnovas, Olivier, Brisou, Gabriel, Cheminant, Morgane, Bay, Jacques-Olivier, Gutierrez, Francisco Llamas, Menard, Cédric, Tarte, Karin, Delfau, Marie-Hélène, Portugues, Cédric, Itti, Emmanuel, Palard-Novello, Xavier, Blanc-Durand, Paul, Al Tabaa, Yassine, Bailly, Clément, Laurent, Camille, and Lemonnier, François
- Published
- 2023
- Full Text
- View/download PDF
5. S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
- Author
-
Amira Marouf, Sammara Chaubard, Jean Marie Michot, Julien Rossignol, Camille Golfier, Olivier Allangba, Laure Philippe, Benoit Tessoulin, Adrien Chauchet, Bénédicte Deau, Lucie Oberic, Jacques Vargaftig, Aline Moignet, Aline Clavert, Rémy Duléry, Gabriel Brisou, Stéphanie Tardy, Virginie Fataccioli, Roch Houot, Rene Olivier Casasnovas, Catherine Thieblemont, Herve Ghesquieres, Sylvain Carras, Steven Le Gouill, Guillaume Cartron, Aurélien Marabelle, Olivier Tournilhac, Gandhi Laurent Damaj, Philippe Gaulard, Laurence De Leval, Francois Lemonnier, Emmanuel Bachy, Olivier Hermine, Lucile Couronné, and Arnaud Jaccard
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2023
- Full Text
- View/download PDF
6. S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY
- Author
-
Roch Houot, Emmanuel Bachy, Guillaume Cartron, Francois-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Rene Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques Olivier Bay, Francisco Llamas, Cedric Menard, Karin Tarte, Marie-Helene Delfau-Larue, Emmanuel Itti, Clément Bailly, Yassine Al Tabaa, Camille Laurent, and Francois Lemonnier
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2023
- Full Text
- View/download PDF
7. Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
- Author
-
Houot, Roch, Bachy, Emmanuel, Cartron, Guillaume, Gros, François-Xavier, Morschhauser, Franck, Oberic, Lucie, Gastinne, Thomas, Feugier, Pierre, Duléry, Rémy, Thieblemont, Catherine, Joris, Magalie, Jardin, Fabrice, Choquet, Sylvain, Casasnovas, Olivier, Brisou, Gabriel, Cheminant, Morgane, Bay, Jacques-Olivier, Gutierrez, Francisco Llamas, Menard, Cédric, Tarte, Karin, Delfau, Marie-Hélène, Portugues, Cédric, Itti, Emmanuel, Palard-Novello, Xavier, Blanc-Durand, Paul, Al Tabaa, Yassine, Bailly, Clément, Laurent, Camille, and Lemonnier, François
- Published
- 2023
- Full Text
- View/download PDF
8. Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy
- Author
-
Camus, Vincent, Houot, Roch, Brisou, Gabriel, Tessoulin, Benoit, Bailly, Sébastien, Sesques, Pierre, Decroocq, Justine, Krzisch, Daphné, Oberic, Lucie, Lemonnier, François, Bouabdallah, Krimo, Campidelli, Arnaud, Tounes, Ledraa, Abraham, Julie, Herbaux, Charles, Morschhauser, Franck, Damaj, Gandhi Laurent, Guidez, Stéphanie, Carras, Sylvain, Fornecker, Luc-Matthieu, Choquet, Sylvain, Hermine, Olivier, Paillassa, Jérome, Chauchet, Adrien, Casasnovas, Olivier, Drieu La Rochelle, Laurianne, Castilla-Llorente, Cristina, Joris, Magalie, Dupont, Vivien, Marquet, Alexandra, Le Gouill, Steven, and Jardin, Fabrice
- Abstract
•TAFA combined with LEN showed limited efficacy after CAR T-cell failure in a high-risk population.•Outcomes were comparable between the TAFA-LEN combination and other treatments for the first progression after CAR T-cell therapy.
- Published
- 2024
- Full Text
- View/download PDF
9. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models
- Author
-
Noushin Mossadegh-Keller, Gabriel Brisou, Alicia Beyou, Bertrand Nadel, and Sandrine Roulland
- Subjects
germinal center (GC) ,follicular lymphoma (FL) ,diffuse large B cell lymphoma (DLBCL) ,genetically engineered mouse (GEMs) ,epigenetic modifier mutations ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Lymphomas are cancers deriving from lymphocytes, arising preferentially in secondary lymphoid organs, and represent the 6th cancer worldwide and the most frequent blood cancer. The majority of B cell Non-Hodgkin lymphomas (B-NHL) develop from germinal center (GC) experienced mature B cells. GCs are transient structures that form in lymphoid organs in response to antigen exposure of naive B cells, and where B cell receptor (BCR) affinity maturation occurs to promote B cell differentiation into memory B and plasma cells producing high-affinity antibodies. Genomic instability associated with the somatic hypermutation (SHM) and class-switch recombination (CSR) processes during GC transit enhance susceptibility to malignant transformation. Most B cell differentiation steps in the GC are at the origin of frequent B cell malignant entities, namely Follicular Lymphoma (FL) and GCB diffuse large B cell lymphomas (GCB-DLBCL). Over the past decade, large sequencing efforts have provided a great boost in the identification of candidate oncogenes and tumor suppressors involved in FL and DLBCL oncogenesis. Mouse models have been instrumental to accurately mimic in vivo lymphoma-specific mutations and interrogate their normal function in the GC context and their oncogenic function leading to lymphoma onset. The limited access of biopsies during the initiating steps of the disease, the cellular and (epi)genetic heterogeneity of individual tumors across and within patients linked to perturbed dynamics of GC ecosystems make the development of genetically engineered mouse models crucial to decipher lymphomagenesis and disease progression and eventually to test the effects of novel targeted therapies. In this review, we provide an overview of some of the important genetically engineered mouse models that have been developed to recapitulate lymphoma-associated (epi)genetic alterations of two frequent GC-derived lymphoma entities: FL and GCB-DLCBL and describe how those mouse models have improved our knowledge of the molecular processes supporting GC B cell transformation.
- Published
- 2021
- Full Text
- View/download PDF
10. The Premalignant Ancestor Cell of t(14;18)+ Lymphoma
- Author
-
Gabriel Brisou, Bertrand Nadel, and Sandrine Roulland
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2021
- Full Text
- View/download PDF
11. Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects.
- Author
-
Juliette Périchou, Florence Ranchon, Chloé Herledan, Laure Huot, Virginie Larbre, Isabelle Carpentier, Anne Lazareth, Lionel Karlin, Karen Beny, Nicolas Vantard, Vérane Schwiertz, Anne Gaelle Caffin, Amandine Baudouin, Pierre Sesques, Gabriel Brisou, Hervé Ghesquières, Gilles Salles, and Catherine Rioufol
- Subjects
Medicine ,Science - Abstract
Long-term multiple myeloma therapy by immunomodulatory drugs (IMiDs) raises the question of management of adverse effects. The aim of this study is to assess the impact of an educational session for patients on the acquisition of knowledge to manage hematologic and thromboembolic adverse effects of IMiDs. In this prospective single-center study, patients attended an educational session with a hospital clinical pharmacist and a nurse. The primary endpoint was the patient's level of knowledge for the management of IMiDs adverse effects, assess with a dedicated questionnaire administered before the session then 1 and 6 months after. Assessment of knowledge was combined with self-assessment of certainty. The secondary endpoints were adherence and IMiD treatment satisfaction. 50 patients were included. Patient knowledge increased at 1 month (p
- Published
- 2020
- Full Text
- View/download PDF
12. Human germinal center transcriptional programs are de-synchronized in B cell lymphoma
- Author
-
Milpied, Pierre, Cervera-Marzal, Iñaki, Mollichella, Marie-Laure, Tesson, Bruno, Brisou, Gabriel, Traverse-Glehen, Alexandra, Salles, Gilles, Spinelli, Lionel, and Nadel, Bertrand
- Published
- 2018
- Full Text
- View/download PDF
13. Mycobacterium riyadhense Pulmonary Infection, France and Bahrain
- Author
-
Sylvain Godreuil, Hélène Marchandin, Anne-Laure Michon, Mikael Ponsada, Georges Chyderiotis, Patrick Brisou, Abdul Bhat, and Gilles Panteix
- Subjects
non-tuberculous mycobacterium ,tuberculosis and other mycobacteria ,bacteria ,pulmonary infection ,emerging pathogen ,France ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Published
- 2012
- Full Text
- View/download PDF
14. A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders
- Author
-
Gabriel Brisou, Aurélie Verney, Thomas Wenner, Lucile Baseggio, Pascale Felman, Evelyne Callet-Bauchu, Bertrand Coiffier, Françoise Berger, Gilles Salles, and Alexandra Traverse-Glehen
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2014
- Full Text
- View/download PDF
15. Outbreak of Pertussis, Kabul, Afghanistan
- Author
-
Emmanuel Sagui, Lénaïck Ollivier, Tiphaine Gaillard, Fabrice Simon, Patrick Brisou, Philippe Puech, and Alain Todesco
- Subjects
whooping cough ,Bordetella pertussis ,Afghanistan ,Kabul ,respiratory tract disease ,military personnel ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Published
- 2008
- Full Text
- View/download PDF
16. The French Military influenza surveillance system (MISS): overview of epidemiological and virological results during four influenza seasons – 2008–2012
- Author
-
Sandrine Duron, Aurélie Mayet, Françoise Lienhard, Rachel Haus-Cheymol, Catherine Verret, Serge Védy, Patrick Le Guen, Laurence Berbineau, Patrick Brisou, Philippe Dubrous, Eric Garnotel, Jean-Baptiste Meynard, Xavier Deparis, Audrey Mérens, Christine Bigaillon, and René Migliani
- Subjects
armed forces ,influenza ,surveillance ,Medicine - Published
- 2013
- Full Text
- View/download PDF
17. A prospective multicentre surveillance study to investigate the risk associated with contaminated sinks in the intensive care unit
- Author
-
Anne-Sophie Valentin, Sandra Dos Santos, Florent Goube, Rémi Gimenes, Marie Decalonne, Laurent Mereghetti, Côme Daniau, Nathalie van der Mee-Marquet, H. Abdoush, S. Alfandari, A. Allaire, L. Aloe, A. Andreo, E. Antoine, C. Aurel, A. Azaouzi, V. Barry-Perdereau, Y. Berrouane, S. Blaise, M. Blanie, S. Bonjean, G.C. Borderan, M. Bounoua, C. Bourigault, V. Brean, A. Cecille, H. Chakaroun, O. Chanay, C. Chauvin, V. Curnier, H. Dalmas, D. Degallaix, F. Del Guidice, J. Delhomme, M. Demasure, C. Denis, F. Diaw, S. Dorel, A. Fourneret-Vivier, B. Fradin, A. Fribourg, B. Fumery, S. Gallais, L. Gazagne, J.P. Genillon, C. Gerbier, A. Glanard, C. Gouin, F. Gourmelen, C. Haond, C. Huart, N. Idri, P. Ionescu, S. Joron, E. Joseph, V. Labonne, B. Laurent, M. Le Coq, M. Lecuru, A. Legrand, O. Lehiani, M. Lepainteur, C. Lesteven, M. Llorens, N. Lugagne, M. Magneney, A. Mahamat, V. Marie, K. Mattioli, M. Mesnil, S. Mien, V. Morange, N. Negrin, C. Neulier, J. Ory, S. Ouzani, A. Perez, F. Pospisil, T. Sevin, A. Thomas-Hervieu, A. Valdes, C. Victoire, B. Vidal-Hollaender, P. Veyres, O. Zamfir, N. Anguel, P. Aussant, C. Badetti, F. Bavozet, J. Bayekula, S. Bedon-Carte, J.P. Bedos, M. Berthon, P.M. Bertrand, E. Brunel, C. Burel, C. Cerf, R. Chelha, D. Combaux, D. Da Silva, C. Damoisel, S. De Rudnicki, J. Debost, L. Desfrere, M. Della-Guardia, E. Dieye, N. Eisenmann, F. Ethuin, L. Favier, S. Fedun, M. Feller, L. Ferreira, P. Fillatre, X. Galin, D. Garot, J. Gaubert Duclos, S. Gette, H. Georges, F. Godde, M. Hamet, M. Hira, J. Hoff, H. Hyvernat, J. Illinger, L. Jacques, J. Joubert, M. Kaidomar, P. Kalfon, H. Kallel, P. Lafforgue, F. Lambiotte, A. Landivier, T. Lazard, F. Le Gall, W. M'fam, J. Mariot, A. Martin, O. Martinet, P. Michaux, O. Michel, A. Mofredj, F. Montini, L. Muller, C. Pommier, J.C. Pottie, F. Prevost, C. Roger, C. Samat, L. Serpin, S. Siami, S. Sidki Alaoui, A. Simaillaud, P.Y. Simonoviez, H. Slimani, J.M. Thouret, D. Toledano, B. Travert, P. Trouiller, G. Trouillet, C. Vescovali, A. Adochitei, M. Amara, S. Arsene, M.N. Bachelier, A. Barrans, O. Belmonte, S. Ben Hadj Yahia, T. Bensaid, G. Beretta-Salaun, D. Bertei, J. Bizet, S. Bleunven, F. Bonfils, R. Bonnet, P. Brisou, P. Cantet, C. Cattoen, C. Chaplain, B. Cordoleani, A. Dao, E. Dorangeon, C. Dupin, E. Farfour, C. Farrugia, M. Fines, S. Fougnot, P. Garnier, M. Guerin, C. Guillet-Caruba, J. Guinard, A. Goux, S. Hammami, E. Heusse, B. Heym, C. Hombrouck Alet, P. Jacquemin, C. Jensen, M.P. Lacomme, E. Lafay, F. Lance, C. Lanselle, J.P. Lavigne, F. Le Gallou, S. Lechat, O. Lemenand, S. Leotard, M. Levast, G. Louis, J. Lourtet, N. Luizy, L. Mereghetti, L. Mignot, O. Moquet, J.C. Navarrot, M. Pancher Lory, L. Parmeland, P. Patoz, S. Poussing, C. Ragot, L. Roudiere, R. Ruimy, V. Sainte Rose, R. Sanchez, H. Seraphin, and M.l. Vanson
- Subjects
inorganic chemicals ,0301 basic medicine ,Microbiology (medical) ,Surveillance study ,030106 microbiology ,Sink (geography) ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Environmental health ,Intensive care ,Medicine ,030212 general & internal medicine ,geography ,geography.geographical_feature_category ,business.industry ,Incidence (epidemiology) ,fungi ,Ventilator-associated pneumonia ,food and beverages ,General Medicine ,Contamination ,medicine.disease ,Intensive care unit ,Infectious Diseases ,business ,human activities ,Waste disposal - Abstract
Objectives The aim was to assess the incidence of sink contamination by multidrug-resistant (MDR) Pseudomonas aeruginosa and Enterobacteriaceae, risk factors for sink contamination and splashing, and their association with clinical infections in the intensive care setting. Methods A prospective French multicentre study (1 January to 30 May 2020) including in each intensive care unit (ICU) a point-prevalence study of sink contamination, a questionnaire of risk factors for sink contamination (sink use, disinfection procedure) and splashing (visible plashes, distance and barrier between sink and bed), and a 3-month prospective infection survey. Results Seventy-three ICUs participated in the study. In total, 50.9% (606/1191) of the sinks were contaminated by MDR bacteria: 41.0% (110/268) of the sinks used only for handwashing, 55.3% (510/923) of those used for waste disposal, 23.0% (62/269) of sinks daily bleached, 59.1% (126/213) of those daily exposed to quaternary ammonium compounds (QACs) and 62.0% (285/460) of those untreated; 459 sinks (38.5%) showed visible splashes and 30.5% (363/1191) were close to the bed ( Discussion Our data showed frequent and multifactorial infectious risks associated with contaminated sinks in ICUs.
- Published
- 2021
- Full Text
- View/download PDF
18. Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
- Author
-
Houot, Roch, Bachy, Emmanuel, Cartron, Guillaume, Gros, François-Xavier, Morschhauser, Franck, Oberic, Lucie, Gastinne, Thomas, Feugier, Pierre, Duléry, Rémy, Thieblemont, Catherine, Joris, Magalie, Jardin, Fabrice, Choquet, Sylvain, Casasnovas, Olivier, Brisou, Gabriel, Cheminant, Morgane, Bay, Jacques-Olivier, Gutierrez, Francisco Llamas, Menard, Cédric, Tarte, Karin, Delfau, Marie-Hélène, Portugues, Cédric, Itti, Emmanuel, Palard-Novello, Xavier, Blanc-Durand, Paul, Al Tabaa, Yassine, Bailly, Clément, Laurent, Camille, and Lemonnier, François
- Published
- 2024
- Full Text
- View/download PDF
19. Listeriosis after fludarabine treatment for chronic lymphocytic leukemia
- Author
-
Hequet, O., de Jaureguiberry, J. P., Jaubert, D., Gisserot, O., Muzellec, Y., and Brisou, P.
- Published
- 1997
- Full Text
- View/download PDF
20. French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): An IFM Study from the Descar-T Registry
- Author
-
Ferment, Benoit, Lambert, Jérôme, Caillot, Denis, Lafon, Ingrid, Karlin, Lionel, Lazareth, Anne, Touzeau, Cyrille, Leleu, Xavier, Moya, Niels, Harel, Stephanie, Perrot, Aurore, Bories, Pierre, Vincent, Laure, Lamure, Sylvain, Mohty, Mohamad, Malard, Florent, Manier, Salomon, Yakoub-Agha, Ibrahim, Stoppa, Anne-Marie, Brisou, Gabriel, Decaux, Olivier, Houot, Roch, Le Gouill, Steven, Facon, Thierry, Avet-Loiseau, Hervé, Moreau, Philippe, and Arnulf, Bertrand
- Published
- 2022
- Full Text
- View/download PDF
21. A case of multiple contamination with methylase ArmA-producing pathogens
- Author
-
Thomas Jové, C. Contargyris, E. Meaudre, P. Brisou, Frédéric Janvier, Patrick Plésiat, M.-P. Otto, Katy Jeannot, A. Mille, Hôpital d'Instruction des Armées Sainte Anne, Service de Santé des Armées, Centre Hospitalier Sainte Anne [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques (RESINFIT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM)-CHU Limoges, Centre National de Référence de la Résistance aux Antibiotiques (CNR), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), and Service de bactériologie [Besançon]
- Subjects
0301 basic medicine ,Pharmacology ,Microbiology (medical) ,Genetics ,Methyltransferase ,030106 microbiology ,Contamination ,Biology ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,Pathogenic organism ,Microbiology ,03 medical and health sciences ,Infectious Diseases ,Pharmacology (medical) ,ComputingMilieux_MISCELLANEOUS - Abstract
International audience
- Published
- 2016
- Full Text
- View/download PDF
22. Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells
- Author
-
Sesques, Pierre, Tordo, Jérémie, Ferrant, Emmanuelle, Safar, Violaine, Wallet, Florent, Dhomps, Anthony, Brisou, Gabriel, Bouafia, Fadhela, Karlin, Lionel, Ghergus, Dana, Golfier, Camille, Lequeu, Helène, Lazareth, Anne, Vercasson, Marlène, Hospital-Gustem, Carole, Schwiertz, Vérane, Choquet, Marion, Sujobert, Pierre, Novelli, Silvana, Mialou, Valérie, Hequet, Olivier, Carras, Sylvain, Fouillet, Ludovic, Lebras, Laure, Guillermin, Yann, Leyronnas, Cécile, Cavalieri, Doriane, Janier, Marc, Ghesquières, Hervé, Salles, Gilles, and Bachy, Emmanuel
- Abstract
Supplemental digital content is available in the text.
- Published
- 2021
- Full Text
- View/download PDF
23. Dermatitis and arthropods (Anobium punctatum and Cimex lectularius) in summer: three case reports
- Author
-
Chrystelle Darles, P. Brisou, Sandrine Pons, Béatrice Fournier, and Tiphaine Gaillard
- Subjects
Male ,Bedbugs ,Entomology ,medicine.medical_specialty ,media_common.quotation_subject ,Zoology ,Dermatitis ,Insect ,Common furniture beetle ,Biology ,medicine.disease_cause ,Young Adult ,Anobium ,Infestation ,medicine ,Mite ,Animals ,Humans ,Arthropods ,Aged ,media_common ,Mites ,Insect Bites and Stings ,General Medicine ,Middle Aged ,biology.organism_classification ,Surgery ,Female ,Seasons ,Arthropod ,Cimex lectularius - Abstract
We report three cases of pruritic dermatitis with erythematous maculopapules, having a similar clinical presentation, in summer, and caused by two different arthropods. In wandering diagnosis since sometimes several months, patients have made entomologic investigations in their home. Two of three samples, have shown an infestation by Anobium punctatum, the common furniture beetle, a xylophagous beetle (usually harmless for human). It may be parasited by Pyemotes ventricosus, a mite known since the 19th century to cause this type of hurt. The third sample contained Cimex lectularius or bedbug, haematophagous insect, classically looked for in endemic zone.
- Published
- 2013
- Full Text
- View/download PDF
24. Mucormycose rhino-cérébrale à Rhizopus oryzae : à propos d’un cas
- Author
-
T. Gaillard, P. Brisou, O. Bausset, O. Mimouni, C. Collet, J.-B. Morvan, C. Darles, and S. Pons
- Subjects
medicine.medical_specialty ,Diabetic ketoacidosis ,medicine.diagnostic_test ,Biochemistry (medical) ,Clinical Biochemistry ,Mucormycosis ,Biology ,medicine.disease ,biology.organism_classification ,Dermatology ,Surgery ,Rhizopus ,Amphotericin B ,Diabetes mellitus ,Biopsy ,medicine ,Sinusitis ,Mycosis ,medicine.drug - Abstract
Summary Mucormycosis infections are rare in France, and are caused by fungi of the class Zygomycetes, order Mucorales. The prognosis of these emergent pathologies remains severe. We report a case of a 44-year-old man, who has been admitted to the Emergency Care Unit, for a fly-away acute sinusitis resistant to antibiotic treatment. Biological parameters revealed a diabetic ketoacidosis. On day 2 after admission, ocular dysfunctions happened. An ethmoido-oculo-cerebral lesion was revealed by a cerebral MRI, suggesting a mucormycosis infection. Isolation of Rhizopus orizae was performed by a surgical histologic biopsy. Mucormycosis agents of are ubiquitary. Rhino-cerebral lesions are the most common clinical manifestations. Diabetic ketoacidosis and hematologic malignancies are respectively the two higher risk factors of mucormycosis development. This angioinvasive fungal infection induces more than a 50 % rate mortality despite the first surgical-line therapy. To conclude, a global therapeutic care and a complete knowledge of this varied clinical fungi infection must be controlled. The actual incidence of diabetes is increased, thus a mucormycosis infection must be evoked in non-responsive head and neck infections.
- Published
- 2011
- Full Text
- View/download PDF
25. Syndromes myélodysplasiques érythroblastopéniques
- Author
-
C. Martinaud, G. Menard, Olivier Gisserot, J.P. de Jaureguiberry, S. Pons, and P. Brisou
- Subjects
medicine.medical_specialty ,Blood transfusion ,Red Cell ,Acquired Pure Red Cell Aplasia ,business.industry ,Myelodysplastic syndromes ,medicine.medical_treatment ,Gastroenterology ,Pure red cell aplasia ,Bone Marrow Aplasia ,medicine.disease ,Surgery ,hemic and lymphatic diseases ,Immunology ,Internal Medicine ,medicine ,Stem cell ,Aplastic anemia ,business - Abstract
Myelodysplastic syndrome with erythroid hypoplasia or erythroblastopenia has not yet been clearly defined, and in most patients it is mistaken for acquired pure red cell aplasia. Including one additional patient reported in this article, a literature review revealed only 50 cases over the last 20 years. These patients were predominantly elderly males, all required regular packed red cell transfusions, and they had a poor prognosis, mainly because of acute transformation. The mechanisms of erythroid aplasia remain unclear. However, recent data suggest the association of an intrinsic stem cell defect with immunological implication.
- Published
- 2011
- Full Text
- View/download PDF
26. A family outbreak due to an emm-type 11 multiresistant strain of Streptococcus pyogenes
- Author
-
C. Martinaud, Anne Bouvet, Tiphaine Gaillard, B. Graffin, F. Carsuzaa, A. Doloy, S. Mallet, R. Poyet, and P. Brisou
- Subjects
Male ,Microbiology (medical) ,emm-type 11 ,streptococcal toxic shock syndrome ,Adolescent ,Genotype ,medicine.drug_class ,Tetracycline ,Streptococcus pyogenes ,Exotoxins ,Biology ,medicine.disease_cause ,Disease Outbreaks ,Macrolide Antibiotics ,SmaI ,Microbiology ,Fatal Outcome ,Bacterial Proteins ,Drug Resistance, Multiple, Bacterial ,Streptococcal Infections ,medicine ,Humans ,Aged, 80 and over ,Family Health ,Antigens, Bacterial ,Lincosamides ,outbreak ,Toxic shock syndrome ,Outbreak ,Kanamycin ,General Medicine ,Middle Aged ,medicine.disease ,Virology ,Anti-Bacterial Agents ,Bacterial Typing Techniques ,Electrophoresis, Gel, Pulsed-Field ,Infectious Diseases ,Bacteraemia ,Female ,prophylaxis ,Carrier Proteins ,Bacterial Outer Membrane Proteins ,medicine.drug - Abstract
Four cases of Streptococcus pyogenes infection due to an emm-type 11 strain, including one with a fatal outcome, occurred within a seven-member family. All strains shared biotype 5, pyrogenic exotoxin genes speB and speC, and resistance to kanamycin, tetracycline, macrolides and lincosamides. The identity of SmaI pulsed-field gel electrophoresis patterns confirmed their clonal origin. This highlights the ability of S. pyogenes to spread rapidly among family members. This first report of a family outbreak due to emm11 S. pyogenes reinforces the importance of surveillance of close family contacts of individuals with invasive streptococcal disease, and provides further support for antibiotic prophylaxis among the elderly.
- Published
- 2010
- Full Text
- View/download PDF
27. Blépharite chronique : quel rôle pour Demodex folliculorum ? À propos d’un cas
- Author
-
T. Gaillard, P. Brisou, Sandrine Pons, Christophe Martinaud, and B. Fournier
- Subjects
medicine.medical_specialty ,biology ,medicine.diagnostic_test ,business.industry ,Physical examination ,General Medicine ,biology.organism_classification ,medicine.disease ,Dermatology ,Demodex folliculorum ,medicine.anatomical_structure ,Rosacea ,parasitic diseases ,medicine ,Mite ,Itching ,medicine.symptom ,business ,Blepharitis ,Demodex ,Nose - Abstract
We present a 73-year-old woman presented to our hospital with a 2 years history of eyes itching. The ophthalmological testing was normal. Physical examination revealed blepharitis and lesions acnea-like on mouth, nose and chest. Biological testing revealed no abnormalities. Histologic study and direct immunofluorescence on a cutaneous biopsy were no contributive. The research of an allergic origine was practised by cutaneous and serological tests and negative. An examination of eyelashes was performed and yielded Demodex. Demodex folliculorum is a mite that is the most common permanent ectoparasite of humans, which is thought to be linked to blepharitis and allergic blepharoconjunctivis with rosacea, although much controversy persists. Recent studies demonstrate a high frequence of chronic blepharitis when Demodex are abundant. Several molecules can be used to treat this infestation. Parasiticide as oral ivermectine may be useful when the infestation is important.
- Published
- 2009
- Full Text
- View/download PDF
28. Moyens biologiques et stratégie diagnostique de la leptospirose neuroméningée. À propos d’un cas
- Author
-
C. Martinaud, P. Brisou, J. Maslin, T. Gaillard, J.-B. Souraud, P. Alla, and A. Faivre
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Cerebral Spinal Fluid ,Gastroenterology ,Internal Medicine ,Medicine ,Biologic Assays ,business - Abstract
Resume Les manifestations cliniques et biologiques des leptospiroses meningees sont trompeuses. Nous presentons le cas d’un homme de 62 ans, sans facteurs de risque, souffrant de cephalees febriles avec liquide cephalorachidien pseudotumoral, par leptospirose meningee pure. Nous discutons a ce propos des moyens diagnostiques disponibles et de leur interet pratique.
- Published
- 2009
- Full Text
- View/download PDF
29. Antiphospholipid antibodies in a family with dehydrated hereditary stomatocytosis
- Author
-
T. Gaillard, C. Martinaud, Jean Delaunay, Olivier Gisserot, P. Brisou, Bruno Graffin, P. Aguilon, Jean Pierre De Jaureguiberry, and Thérèse Cynober
- Subjects
chemistry.chemical_compound ,chemistry ,biology ,business.industry ,Immunology ,Dehydrated hereditary stomatocytosis ,biology.protein ,Medicine ,Hematology ,Phosphatidylserine ,Antibody ,business - Published
- 2008
- Full Text
- View/download PDF
30. Infections à pneumocoque
- Author
-
Y. Muzellec, J.-M. Chamouilli, T. Gaillard, and P. Brisou
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,Medicine ,business - Abstract
Resume Les infections a pneumocoque representent aujourd'hui un probleme de sante publique. Le pneumocoque est une cause majeure des infections communautaires invasives et non invasives du nourrisson et de l'enfant. Les infections invasives, notamment les meningites, restent graves, avec un taux de mortalite superieur a 8 % et un risque eleve de sequelles. Chez le petit enfant, leur expression clinique peut etre atypique. Le diagnostic biologique beneficie d'avancees techniques comme la detection rapide d'un antigene par immunochromatographie sur membrane, encore a evaluer chez l'enfant. L'augmentation de la frequence des souches de pneumocoque de sensibilite diminuee a la penicilline impose d'adapter la therapeutique a la pathologie et a l'epidemiologie. La frequence, la gravite et la resistance des infections a pneumocoque justifient la vaccination par le vaccin conjugue Prevenar® ou le vaccin Pneumo 23® selon l'âge de l'enfant. Une surveillance locale, nationale et internationale permet en outre d'emettre des recommandations en matiere de traitement probabiliste et de vaccination.
- Published
- 2004
- Full Text
- View/download PDF
31. Infecciones por neumococos
- Author
-
P. Brisou, T. Gaillard, J.-M. Chamouilli, and Y. Muzellec
- Subjects
Philosophy ,Humanities - Abstract
Resumen Las infecciones neumococicas constituyen hoy en dia un problema de salud publica. El neumococo es una causa grave de infecciones invasivas y no invasivas de lactantes y ninos en ambientes comunitarios. Las infecciones invasivas, en especial las meningitis, siguen siendo graves, con una tasa de mortalidad superior al 8% y gran riesgo de secuelas. En los ninos pequenos, su expresion clinica puede ser atipica. El diagnostico de laboratorio ha beneficiado de los avances tecnicos, como la deteccion rapida de un antigeno mediante inmunocromatografia sobre membrana, tecnica aun no evaluada en los ninos. El aumento de la frecuencia de cepas de neumococos con sensibilidad reducida a la penicilina exige que se adapte el tratamiento a la enfermedad y a la epidemiologia. La frecuencia, la gravedad y la resistencia de las infecciones por neumococos justifican la vacunacion mediante distintas vacunas segun la edad del nino. Por otra parte, el control local, nacional e internacional permite establecer recomendaciones respecto al tratamiento empirico y a la vacunacion.
- Published
- 2004
- Full Text
- View/download PDF
32. Mycobacterium riyadhense Pulmonary Infection, France and Bahrain
- Author
-
Mikael Ponsada, P. Brisou, Sylvain Godreuil, Anne-Laure Michon, Georges Chyderiotis, Abdul Bhat, Gilles Panteix, and Hélène Marchandin
- Subjects
Microbiology (medical) ,Tuberculosis ,Letter ,Epidemiology ,Tuberculin ,lcsh:Medicine ,pulmonary infection ,Microbiology ,lcsh:Infectious and parasitic diseases ,Clarithromycin ,medicine ,lcsh:RC109-216 ,emerging pathogen ,Letters to the Editor ,bacteria ,Ethambutol ,biology ,business.industry ,Isoniazid ,lcsh:R ,non-tuberculous mycobacterium ,Pyrazinamide ,bacterial infections and mycoses ,medicine.disease ,biology.organism_classification ,tuberculosis and other mycobacteria ,Infectious Diseases ,Immunology ,Bahrain ,Sputum ,France ,medicine.symptom ,business ,medicine.drug ,Mycobacterium - Abstract
To the Editor: Mycobacterium riyadhense is a newly described mycobacterial species that is potentially pathogenic for humans. Extrapulmonary infection with this nontuberculous mycobacterium (NTM) has been reported (1).We report 2 cases of pulmonary infection with this NTM. The first case of infection was in a 39-year-old woman who was admitted to Toulon Military Hospital, Toulon, France, in December 2005 with suspected pulmonary tuberculosis. For 1 month, the patient had a persistent cough, fever, asthenia, and weight loss. Findings on chest radiographs were suggestive of tuberculosis, with cavitation in the right upper lobe, and the tuberculin skin test reaction was positive. Sputum specimens collected on 3 consecutive days were negative for acid-fast bacilli (AFB), but broth cultures (BacT/ALERT 3D system; bioMerieux, Marcy l’Etoile, France) yielded mycobacterial growth. We used 4 multiplex line-probe assays to identify the mycobacteria: GenoType MTBC (Hain Lifescience, Nehren, Germany) identified the organisms as members of the M. tuberculosis complex (MTBC; with a nonspecific reaction, banding pattern 1, 2, 3); GenoType Mycobacterium CM (Common Mycobacteria) (Hain Lifescience) kit and GenoType Mycobacterium AS (Additional Species) (Hain Lifescience) kit identified the strains as members of the MTBC and as unspecified Mycobacterium species, respectively; and INNO-LiPA MYCOBACTERIA v2 (Innogenetics, Ghent, Belgium) yielded a Mycobacterium-positive reaction by genus probe but no species-specific result. Following the criteria of the American Thoracic Society, we considered the isolates as the pathogens responsible for the patient’s respiratory disease (2). The patient was treated with a combination of isoniazid (INH), rifampin (RIF), ethambutol (EMB), and pyrazinamide (PZA). EMB and PZA were continued for 2 months; INH and RIF were continued for 10 months (Table), at which time the patient was considered cured. Table Clinical characteristics, drug susceptibility testing, and outcome for 3 case-patients with Mycobacterium riyadhense infection, France and Bahrain* The second case of infection was in a 43-year-old man who was admitted to Awali Hospital, Awali, Bahrain, in November 2006. The patient reported malaise, insomnia, cough, weight loss, and anorexia. Radiographs showed features suggestive of tuberculosis (left upper lobe consolidation with focal cavitation). Sputum specimens collected on 3 consecutive days were positive for AFB and mycobacterial growth. To identify the pathogen(s), we used the same 4 mutiplex line-probe assays as used for case-patient 1, and results were similar. The identified strain was considered to be the pathogen responsible for the respiratory disease (2). The patient was treated with a combination of clarithromycin (CLR) and ciprofloxacin (CIP) for 12 months; however, he had a clinical and microbiological (i.e., positive for AFB and culture results with the same NTM) relapse during this treatment. In November 2007, 3 sputum specimens from the patient were positive for AFB, and cultures yielded a mycobacterial strain identical to that identified by the assays. The patient was treated with antituberculous drugs (INH, RIF, EMB, PZA, plus CLR and CIP) for 6 months, and then INH, RIF, CLR, CIP were continued for 2 additional months (Table), after which the patient showed clinical improvement. In the 2 cases, molecular identification of the isolates as M. riyadhense was achieved by using partial hsp65 and rpoB gene sequencing, which was based on the high level of sequence identities with the type strain of M. riyadhense and a distance score of 3.5 and 4.6, respectively, to the next species, “M. simulans” (Table). Broth microdilution panels (SLOMYCO Sensititer; Trek Diagnosis Systems, Cleveland, OH, USA) were used to determine drug susceptibility (Table) (3). Commercial probes are frequently used for rapid identification of mycobacterial species (4); however, M. riyadhense and other recently proposed NTMs (e.g., M. kumamotonense and “M. simulans”) cross-react with MTBC DNA probes and may be missed by line-probe assays (5,6). With the emergence of new NTM species, commercial probes could fail to discriminate between species, leaving clinical isolates either unidentified or misidentified. Because of its ease of use, accuracy, and discriminatory power, multilocus sequence analysis may soon become the standard for routine NTM species identification. We have shown evidence for the pathogenic role of M. riyadhense in pulmonary diseases, a pathogen that has previously been reported to have extrapulmonary pathogenicity (1). Clinical and radiologic signs and symptoms of pulmonary infection caused by M. riyadhense, including cough, weight loss, fever, and cavitating lung lesions, were similar to those in typical cases caused by MTBC strains. van Ingen et al. (7) suggested that the region of difference 1 (RD1) virulence locus identified in MTBC members may also play a crucial role in virulence of some NTM species. These authors found RD1 genes in NTMs that were causing human disease, including M. kansasii, M. szulgai, M. marinum, and the type strain of M. riyadhense (7). We confirmed the presence of RD1 esat-6 and cfp-10 genes in the M. riyadhense isolates reported here (GenBank accession nos. {"type":"entrez-nucleotide-range","attrs":{"text":"JF896090-JF896093","start_term":"JF896090","end_term":"JF896093","start_term_id":"348167248","end_term_id":"348167254"}}JF896090-JF896093). Because M. riyadhense is an emerging pathogen with, to our knowledge, only 1 previously reported extrapulmonary case of infection (1), the optimal treatment for infected patients is unknown. Our results and drug susceptibility testing indicate that antituberculous drugs, including INH, RMP, and EMB, are effective against M. riyadhense infection (Table), but the combination of CLR plus CIP was not effective in 1 case-patient reported here, despite in vitro susceptibility to both drugs.
- Published
- 2012
33. Détection simultanée d’une clonalité T et d’un transcrit FIP1L1-PDGFRA au cours d’un syndrome hyperéosinophilique
- Author
-
P. Brisou, C. Martinaud, J.-M. Cournac, J.P. de Jaureguiberry, J.-B. Souraud, S. Pons, and G. Menard
- Subjects
Chronic eosinophilic leukemia ,medicine.medical_specialty ,Hypereosinophilic syndrome ,business.industry ,Gastroenterology ,Lymphoproliferative disorders ,Hypereosinophilia ,PDGFRA ,medicine.disease ,Asymptomatic ,Molecular biology ,Endocrinology ,Imatinib mesylate ,Fusion transcript ,hemic and lymphatic diseases ,Internal medicine ,Internal Medicine ,medicine ,medicine.symptom ,business - Abstract
We report a 49-year-old man suffering from chronic hypereosinophilia whose biological tests revealed a gene rearrangement between FIP1L1 and PDGFRA as well as a T-cell clonality. After 1 year of therapy with imatinib mesylate (100 mg daily), the patient was clinically asymptomatic, the fusion transcript was undetectable using RTQ-PCR and no lymphoproliferative disorders occurred. This unique combination raises the question of the physiopathology of such a grey zone hypereosinophilia and their management.
- Published
- 2011
- Full Text
- View/download PDF
34. Syndrome d’activation macrophagique révélant une maladie de Hodgkin chez un sujet âgé
- Author
-
J.-M. Cournac, P. Brisou, J.P. de Jaureguiberry, T. Gaillard, C. Darles, S. Pons, and C. Martinaud
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,hemic and lymphatic diseases ,Gastroenterology ,Internal Medicine ,medicine ,Hodgkin lymphoma ,business - Abstract
Resume Le syndrome d’activation macrophagique (SAM) est un syndrome immunologique rare, d’evolution rapidement fatale en l’absence de traitement. Si les lymphomes sont des causes classiques de SAM, l’association a un lymphome de Hodgkin est exceptionnelle. Nous rapportons l’observation d’un homme de 79 ans chez qui le diagnostic de SAM revelait un lymphome de Hodgkin d’issue fatale. Nous discutons l’interet des dosages du sCD25 et de l’interleukine 18 lorsque le diagnostic est difficile, ainsi que les donnees recentes sur le SAM associe a un lymphome de Hodgkin.
- Published
- 2011
- Full Text
- View/download PDF
35. C'est long, comme lacunes !
- Author
-
S. Marlier, Serge Cremades, P Brisou, P. Carli, and J.F. Paris
- Subjects
Text mining ,business.industry ,Gastroenterology ,Internal Medicine ,Medicine ,Actinomycosis ,Anatomy ,business ,medicine.disease - Published
- 2001
- Full Text
- View/download PDF
36. Endocardite infectieuse à Kytococcus schroeteri
- Author
-
F. Pons, C. Martinaud, P. Brisou, R. Carlioz, and R. Poyet
- Subjects
Prosthetic valve ,medicine.medical_specialty ,Kytococcus schroeteri ,Infectious Diseases ,Bacterial etiology ,business.industry ,Aortic valve surgery ,medicine ,Endocarditis ,medicine.disease ,business ,Surgery - Published
- 2010
- Full Text
- View/download PDF
37. Bactériémie à Actinobaculum schaali chez un homme âgé
- Author
-
T. Gaillard, P. Rivière, J. Maslin, R. Fournier, F. Trueba, P. Brisou, and C. Martinaud
- Subjects
Infectious Diseases ,business.industry ,Medicine ,business - Published
- 2008
- Full Text
- View/download PDF
38. Outbreak of Pertussis, Kabul, Afghanistan
- Author
-
L. Ollivier, P. Brisou, Alain Todesco, Philippe Puech, Fabrice Simon, Tiphaine Gaillard, and Emmanuel Sagui
- Subjects
Adult ,Microbiology (medical) ,Warfare ,Pediatrics ,medicine.medical_specialty ,Bordetella pertussis ,Letter ,Epidemiology ,Attack rate ,lcsh:Medicine ,Disease Outbreaks ,respiratory tract disease ,lcsh:Infectious and parasitic diseases ,medicine ,Humans ,whooping cough ,lcsh:RC109-216 ,Whooping cough ,biology ,Tetanus ,business.industry ,Diphtheria ,Kabul ,lcsh:R ,Afghanistan ,Outbreak ,Respiratory infection ,Middle Aged ,medicine.disease ,biology.organism_classification ,Vaccination ,Infectious Diseases ,Immunology ,military personnel ,business - Abstract
To the Editor: Infectious diseases are the main cause of illness for armed forces in conflict (1), resulting in decreases in operational efficiency. The International Security Assistance Force (ISAF) in Afghanistan is a multinational force operating under the auspices of the North Atlantic Treaty Organization (NATO). As part of ISAF, French troops operate in Kabul and its surroundings, within a 70-km radius. French medical facilities consist of a French field hospital and a primary care center. The facilities support 4,000 soldiers, 1,048 of whom are French. Troop disease, including acute respiratory disease (ARD), is routinely monitored through French Army and NATO surveillance systems. We report an outbreak of ARD in the multinational force in which pertussis cases were identified by using laboratory tests and epidemiologic criteria. In November 2006, a substantial increase of ARD was detected in soldiers of different nationalities (Figure), with a 10-fold increase among French troops at week 51. Patients with persistent cough or dyspnea were referred to the field hospital, in a nonrandomized manner, and those with a 2-week history of cough underwent serologic tests. Samples were sent to France and were analyzed at Hopital Saint Anne, Toulon, France. Immunoglobulin (Ig) G antibodies to Bordetella pertussis antigens (pertussis toxin, filamentous hemagglutinin, and adenylcyclase) were determined by a Western blot assay (MarDx Diagnostics, Carlsbad, CA, USA). Recent infection was diagnosed by finding high levels of antibodies to pertussis toxin compared to results for standardized positive and negative samples, in concurrence with the fact that no soldier had been vaccinated against pertussis after childhood. IgG and IgA antibodies to Chlamydia pneumoniae were determined by a semiquantitative method that assessed samples’ absorbance value in optical density (SeroCP Quant IgG and Quant IgA, Savyon Diangostics, Ashdod, Israel). Recent infection to Mycoplasma pneumoniae was assessed by detecting IgM antibodies with a specific enzyme immunoassay (Platelia Mycoplasma pneumoniae, Biorad, Hercules, CA, USA) and by using a semiquantitative method to detect IgM and IgG antibodies with patented gelatin particles sensitized with cell membrane components of M. pneumoniae (Serodia Myco II, Fujirebio, Malvern, PA, USA). Coxiella burnetii infection was assessed by indirect immunofluorescence assay (Coxiella burnetii Spot IF, bioMerieux, Marcy l’Etoile, France). Figure Number of acute respiratory diseases cases, according to troop nationality. UK, United Kingdom. A color version of this figure is available online: www.cdc.gov/EID/content/14/7/1173-G.htm Statistical analysis was performed with Epi Info v3.4 software package (Centers for Disease Control [CDC], Atlanta, GA, USA). Quantitative variables were compared by using the Kruskall-Wallis test. From the third week of December 2006 until the third week of January 2007, 209 French soldiers sought treatment at the French medical facilities for stereotyped acute febrile respiratory infection, which represents a cumulative attack rate of 20% on clinical grounds. Thirty-nine French soldiers and 10 non-French soldiers or local civilian workers were then referred to the field hospital. All patients had a 24-h history of fever >38.5°C and nonspecific ear, nose, and throat symptoms, mainly a sore throat. Cough was unremarkable, without whoops. Fourteen of the 49 patients were hospitalized for severe dyspnea. The difference in median age was not significant between inpatients (26 [range 20–57] years) and outpatients (36 [range 21–53] years, p = 0.15). Twenty-seven blood samples were taken, 24 from French troops, 2 from British troops, and 1 from Polish patients. Six patients, including 3 French soldiers, had recent pertussis. No significant difference in age was found between patients with pertussis and those with non–pertussis ARD (36 [range 27–51] versus 33 [range 20–63] years; p = 0.39). No pertussis patient had been vaccinated against the illness since childhood. One patient had evidence of recent infection with M. pneumoniae, and another with C. pneumoniae. No recent infection involved C. burnetii. All patients with ARD had a favorable outcome. This outbreak of ARD among troops in Afghanistan highlights the importance of nontraumatic illness in wartime when military field conditions enhance exposure to, and incidence of, endemic diseases. Although our study did not include systematic laboratory confirmation for all cases of ARD in soldiers because of field conditions, this outbreak was mainly due to pertussis: most cases were defined by a cough lasting >2 wk, took place in an outbreak setting, and were (for 6 patients) confirmed by laboratory tests. CDC requirements were followed to ascertain confirmed cases (2). This outbreak also involved British troops; after the 2 cases we described, 2 additional serologically confirmed cases and 1 probable confirmed case were discovered among symptomatic British returnees (3). Pertussis, which remains endemic in developing countries (4), was reported in northeastern Afghanistan in 2002 (5), but was never biologically ascertained nor reported in Kabul. This outbreak elicits 3 main questions. First, how can ARD transmission be stopped under field conditions? Besides prophylactic antibiotherapy, isolation of suspected case-patients is not achievable because of limited number of beds in medical facilities and high-person density in barracks and dining halls. To minimize transmission, patients and caregivers should wear masks. Second, what prophylactic antibiotherapy should be given? We recommend a 3-day regimen of azithromycin because it is as efficient as erythromycin in preventing spread of pertussis (6), targets most intracellular bacteria involved in ARD, and offers the best compliance (7). Finally, should soldiers be vaccinated against pertussis for overseas campaigns? In France, no booster vaccination is given after 13 years of age (8). Because acellular vaccines do not ensure immunity for >6 years (5), no French soldier has immunity to pertussis. We therefore advocate booster vaccination before overseas campaigns. Pertussis vaccination is widely available in combination with vaccination against, at minimum, diphtheria and tetanus, but these combination vaccines can only be administered once in an adult’s life and only 2 years after previous vaccination against diphtheria or tetanus. Monovalent vaccines against pertussis must be made more widely available for multinational troops in field conditions.
- Published
- 2008
- Full Text
- View/download PDF
39. Observatoire régional du pneumocoque. Bilan 1995 de la région provençale
- Author
-
C. Payen, F. Duluc, H. Chardon, O. Bellon, M.F. Lacombe, P. Rousselier, M. Bietrix, C. May, F. Durand, J.J. Bertrand, P. Brisou, A. Merabet, P. Geslin, E. Lagier, H. Lefrand, J. Carrere, B. Cordoleani, A. Michel Nguyen, and L. Collet
- Subjects
Gynecology ,medicine.medical_specialty ,Infectious Diseases ,medicine ,Biology - Abstract
Resume Afin de determiner l'epidemiologie locale de la region provencale vis-a-vis de S. pneumoniae , 14 laboratoires de microbiologie ont participe a cet observatoire durant la totalite de l'annee 1995 permettant ainsi le recueil exhaustif de donnees concemant 516 souches isolees de 460 patients. La repartition par âge (187 enfants), sexe (293 hommes et 165 femmes) et serotype a ete etudiee pour l'ensemble des souches et pour les diverses categories de resistance a la penicilline puis comparee aux donnees de la litterature. Enfin une etude de la performance du depistage des souches de sensibilite anormale a la penicilline et au cefotaxime a ete realisee en utilisant des disques d'oxacilline (charges a 1 ou 5 mg/l) et de loracarbef. Cette etude confirme l'augmentation de la resistance de ces souches a la penicilline (29 %) et le caractere multiresistant des souches de sensibilite anormale a la penicilline. On constate une activite bien conservee de l'amoxicilline et du cefotaxime (2 % et 0,2 % de souches resistantes seulement).
- Published
- 1997
- Full Text
- View/download PDF
40. Septic nonunions of lower limb long bones: don't neglect Propionibacterium acnes!
- Author
-
Christophe Gaillard, Marc Dupond, P. Brisou, and Tiphaine Gaillard
- Subjects
Adult ,medicine.medical_specialty ,medicine.drug_class ,Propionibacterium ,medicine.medical_treatment ,media_common.quotation_subject ,Nonunion ,Antibiotics ,Neglect ,Bone Infection ,Propionibacterium acnes ,Fracture Fixation, Internal ,medicine ,Internal fixation ,Humans ,Surgical Wound Infection ,media_common ,Fracture Healing ,biology ,business.industry ,Amoxicillin ,General Medicine ,Perioperative ,Middle Aged ,biology.organism_classification ,medicine.disease ,Surgery ,Anti-Bacterial Agents ,Tibial Fractures ,Treatment Outcome ,Lower Extremity ,Fractures, Ununited ,Rifampin ,business - Abstract
We report 3 clinical cases of septic nonunions of lower limb long bones in which the pathogenicity of Propionibacterium acnes was retained after several weeks of poor outcome. The patients had fractures that were treated by internal fixation, without initially suspected infection. The diagnosis of delayed union coincided with the onset of treatment. Support was performed in 2 steps, allowing for the collection of several deep samples that were referred for microbiological analysis. Molecular techniques for microbiological investigation were performed on perioperative samples and were not contributive. The detection of P acnes, which was identified after several days of incubation, prompted us to consider the role of this bacterium. The presence of P acnes is regularly interpreted as contamination of samples during collection or handling in the laboratory. A multidisciplinary decision to make the diagnosis of surgical site infection with P acnes and specific antibiotic treatment for several months led to consolidation in all the patients. The ability of bacteria of the genus Propionibacterium to cause insidious surgical site infections should not be underestimated, and more extensive sample incubation is essential to diagnose such infections.
- Published
- 2013
41. Answer to December 2012 Photo Quiz
- Author
-
S. Pons, T. Gaillard, P. Aguilon, C. Darles, and P. Brisou
- Subjects
Microbiology (medical) ,biology ,business.industry ,Outbreak ,Photo Quiz ,biology.organism_classification ,medicine.disease ,Virology ,Cyclospora cayetanensis ,Cyclospora ,Diarrhea ,Parasitology ,Trichrome ,medicine ,Parasite hosting ,Cyclospora infection ,medicine.symptom ,business - Abstract
Answer: Cyclospora cayetanensis. Cyclospora cayetanensis is an intestinal coccidian protozoon that has emerged as a significant human infectious agent worldwide, causing self-limiting gastroenteritis in immunocompetent hosts. Human-to-human spread of the parasite occurs indirectly via the environment through oocysts in contaminated water, food, or soil. The parasite has a cosmopolitan distribution and is endemic in tropical and subtropical areas (3). The parasite is commonly limited to travelers to Latin America, the Indian subcontinent, and Southeast Asia, including China (4); therefore, infection with Cyclospora cayetanensis is known as traveler's diarrhea (5). Cyclospora cayetanensis is an important cause of waterborne and food-borne outbreaks due to imported fruits and vegetables from developing countries. The underreporting of infection with this parasite likely occurs because standard examinations for ova and parasites may not include the identification of Cyclospora oocysts. This oversight is at least partly due to the lack of awareness of this disease among the public and medical workers (1). The following criteria have been established for the diagnosis of cyclosporiasis (by the CDC in 1997): detection of oocysts in stool, intestinal fluid, or small bowel biopsy specimens by microscopic examination; demonstration of oocyst sporulation; and detection by molecular methods (not a routine parasitology screening tool) (2). Cyclospora cayetanensis oocysts are spherical and between 8.0 and 10 μm in diameter, with a 50-nm-thick wall and an outer threadlike coat, which is referred to as a wrinkle by some researchers (see Fig. 1a and b in the photo quiz). Diagnostic tests also include phase-contrast microscopy, modified acid-fast staining with variable staining (from pale to red) (see Fig. 1c and d in the photo quiz), and autofluorescence with UV illumination. Ova and parasite exams typically include only direct and concentrated microscopic exams and trichrome stains without modified acid-fast staining or autofluorescence testing. Multiple stool specimens collected on subsequent days are required because parasites are shed intermittently. Of note, two of our patient's specimens were positive, and one was negative. The treatment for Cyclospora infection is a 7-day course of oral trimethoprim-sulfamethoxazole, which proved to be effective for our patient. Health care providers should evaluate Cyclospora infection in patients presenting long-lasting diarrheal illness and order the appropriate tests for this parasite. (See page 3821 in this issue [doi:10.1128/JCM.00256-12] for photo quiz case presentation)
- Published
- 2012
42. Watery diarrhea in an immune-competent traveler
- Author
-
C. Darles, S. Pons, P. Aguilon, P. Brisou, and T. Gaillard
- Subjects
Microbiology (medical) ,Adult ,Diarrhea ,Male ,Pediatrics ,medicine.medical_specialty ,Microscopy ,Travel ,business.industry ,Photo Quiz ,Fresh food ,Southeast asia ,Cyclospora ,Feces ,Immune system ,Immunology ,Medicine ,Humans ,Medical history ,Watery diarrhea ,Cyclosporiasis ,business - Abstract
A 43-year-old man presented to our hospital with a 15-day history of watery diarrhea. He did not report any unusual medical history except for multiple stays in Southeast Asia, including China, where he ate local and fresh food products. He had symptoms of gastroenteritis with watery diarrhea, loss
- Published
- 2012
43. Acinetobacter parvus bacteraemia community-acquired
- Author
-
Chrystelle Darles, Sandrine Pons, Charles Soler, Christophe Martinaud, P. Brisou, and Tiphaine Gaillard
- Subjects
Microbiology (medical) ,DNA, Bacterial ,Male ,Bacteremia ,Microbiology ,DNA, Ribosomal ,Sepsis ,Intensive care ,RNA, Ribosomal, 16S ,Acinetobacter parvus ,medicine ,Humans ,Acinetobacter species ,Aged, 80 and over ,biology ,Acinetobacter ,General Medicine ,Sequence Analysis, DNA ,biology.organism_classification ,medicine.disease ,Acinetobacter baumannii ,Community-Acquired Infections ,Infectious Diseases ,Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ,Gene sequence ,Acinetobacter Infections - Abstract
Clinicians are generally familiar with Acinetobacter baumannii as an aetiological agent of serious nosocomial infections in intensive care units. Other Acinetobacter species can also be responsible for life-threatening sepsis. Here, we report about a bacteraemia caused by Acinetobacter parvus, community-acquired, identified with a 16S rRNA gene sequence analysis and the MALDI-TOF mass spectrometry system.
- Published
- 2012
44. Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry
- Author
-
Brisou, Gabriel, Cartron, Guillaume, Bachy, Emmanuel, Thieblemont, Catherine, Castilla-Llorente, Cristina, Le Bras, Fabien, Gros, François-Xavier, Loschi, Michael, Houot, Roch, Dulery, Remy, Jardin, Fabrice, Joris, Magalie, Sylvain, Choquet, Morschhauser, Franck, Guidez, Stephanie, Hermine, Olivier, Drieu La Rochelle, Laurianne, Carras, Sylvain, Guffroy, Blandine, Bories, Pierre, Casasnovas, Rene-Olivier, Abraham, Julie, Le Gouill, Steven, Cony-Makhoul, Pascale, Gat, Elodie, and Tessoulin, Benoit
- Abstract
Background and Significance:
- Published
- 2023
- Full Text
- View/download PDF
45. Single-Cell Longitudinal Characterization of FL Heterogeneity and Residual Disease in the Bone Marrow from Low-Tumor Burden FL Enrolled in the Flirt Clinical Trial
- Author
-
Beyou, Alicia, Leonard, Simon, Papa, Ilenia, Mossadegh-Keller, Noushin, Baaklini, Sabrina, Spinelli, Lionel, Hoare, Owen, Nadel, Bertrand, Milpied, Pierre, Dulong, Joelle, Monvoisin, Céline, Brisou, Gabriel, Cartron, Guillaume, Tarte, Karin, and Roulland, Sandrine
- Abstract
Follicular Lymphoma (FL) remains a clinically challenging disease as most patients undergo a succession of clinical response/relapse cycles suggesting that current therapies do not eradicate residual tumor cells. Genetic studies suggest that FL relapses seed from a reservoir of rare Cancer Precursor Cells (CPCs), which likely remain resistant to treatment due to their homing to propitious niches such as the bone marrow (BM) and/or to the acquisition of a specific functional B-cell state. Yet, the rarity of such CPCs and the use of bulk sequencing technologies have so far hampered their direct characterization. Profiling CPC remains thus a major challenge in the FL field. Here, we identify and characterize FL cells before/after rituximab monotherapy within the BM of low tumor burden FL, looking for CPC-like cells supporting minimal residual disease.
- Published
- 2023
- Full Text
- View/download PDF
46. A Single Cell Atlas of Diffuse Large B Cell Lymphomas Reveals Distinct Cellular States Predictive of Outcomes
- Author
-
Baaklini, Sabrina, Sarrabay, Alexandre, Barthelemy, Camille, Dahbi, Laila, Gil, Laurine, Mossadegh-Keller, Noushin, Navarro, Jean-Marc, Huber, Caroline, Fenouil, Romain, Escaliere, Bertrand, Trombetta, Romane, Pujol, Marine, Gaulard, Philippe, Riviere, Benjamin, Dartigues, Peggy, Llamas Gutierrez, Francesco, Pangault, Celine, Jardin, Fabrice, Lemonnier, Francois, Brisou, Gabriel, Haioun, Corinne, Gravelle, Pauline, Laurent, Camille, Spinelli, Lionel, Huang, C Chris, Stokes, Matthew E, Seth, Sahil, Ortiz, Maria, Gandhi, Anita K., Nadel, Bertrand, Milpied, Pierre, and Roulland, Sandrine
- Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive B-cell lymphoma with high clinical and biological heterogeneity. Despite current effective immunochemotherapy, up to 40% of patients do not respond or develop refractory disease. DLBCL is characterized by two major cell-of-origin (COO) subtypes, germinal center B cell-like (GCB) and activated B cell-like (ABC), with recent research uncovering additional molecular subgroups based on genomic alterations or tumor microenvironment (TME) features. However, current classifiers use bulk or deconvolution profiling which blurs intra-tumor heterogeneity, hindering the discovery of true functional cell states underlying clinical diversity. Here, we constructed a multimodal single-cell atlas of 62 DLBCL cases, integrating single-cell transcriptomes, immune repertoire and genetic features, to decrypt recurrent B cell states and TME ecosystems while identifying clinically relevant prognostic biomarkers (Fig.1).
- Published
- 2023
- Full Text
- View/download PDF
47. Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa
- Author
-
Ysebaert, Loic, Lemonnier, Francois, Brisou, Gabriel, Casasnovas, Olivier, Pica, Gian Matteo, Bachy, Emmanuel, Fouillet, Ludovic, Abraham, Julie, Guidez, Stephanie, André, Marc, Cartron, Guillaume, Guieze, Romain, Carras, Sylvain, Tessoulin, Benoit, Houot, Roch, Slama, Bohrane, Bonnet, Christophe, Fornecker, Luc-Matthieu, Delfau, Marie-Helene, Sarkozy, Clementine, Laurent, Camille, Ribrag, Vincent, and Morschhauser, Franck
- Abstract
Background:Tazemetostat (TAZ), an enhancer of zeste homolog 2 (EZH2) inhibitor, is approved by the US Food and Drug Administration for the treatment of patients with relapsed/refractory (R/R) follicular lymphoma (FL) whose disease has mutant (MT) EZH2and who have received ≥2 prior therapies or with R/R FL who have no satisfactory alternative treatment options. We previously reported that the RP2D of TAZ in combination with R-CHOP was 800mg BID in the phase 1 part of Epi-RCHOP study (NCT02889523). Here, we report results of the phase 2 part evaluating TAZ with R-CHOP + rituximab maintenance in a cohort of previously untreated high-risk FL patients.
- Published
- 2023
- Full Text
- View/download PDF
48. Real-Word Experience of CAR T-Cells in Patients with Relapsed/Refractory Follicular Lymphoma : A Descart Registry Analysis from the Lysa
- Author
-
Ysebaert, Loic, Houot, Roch, Casasnovas, Olivier, Sylvain, Choquet, Jardin, Fabrice, Loschi, Michael, Brisou, Gabriel, Thieblemont, Catherine, Bay, Jacques-Olivier, Castilla-Llorente, Cristina, Fradon, Tom, Le Gouill, Steven, Morschhauser, Franck, Cartron, Guillaume, and Bachy, Emmanuel
- Abstract
Background:Anti-CD19 CAR T-cells have revolutionized the treatment of aggressive B-cell non-Hodgkin lymphomas (NHL) by demonstrating durable responses. Although follow-up remain short, axicabtagene ciloleucel (axi-cel, ZUMA-5) and tisagenlecleucel (tisa-cel, ELARA) demonstrated promising complete response rates (CRR) of 86% and 69%, respectively, in phase II trials including relapsed or refractory (R/R) follicular lymphoma (FL).. Tisa-cel and axi-cel are now approved after at least 2 lines of systemic therapy by the FDA. Few real-word evidence (RWE) data have been reported so far.
- Published
- 2023
- Full Text
- View/download PDF
49. French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): Update of the IFM Study from the Descar-T Registry
- Author
-
Cayla, Sarah, Ferment, Benoit, Bigot, Noemie, Caillot, Denis, Lafon, Ingrid, Karlin, Lionel, Lazareth, Anne, Touzeau, Cyrille, Leleu, Xavier, Moya, Niels, Harel, Stephanie, Perrot, Aurore, Bories, Pierre, Vincent, Laure, Lamure, Sylvain, Mohty, Mohamad, Malard, Florent, Manier, Salomon, Yakoub-Agha, Ibrahim, Stoppa, Anne-Marie, Brisou, Gabriel, Decaux, Olivier, Houot, Roch, Le Gouill, Steven, Lambert, Jerome, Facon, Thierry, Avet Loiseau, Herve, Moreau, Philippe, and Arnulf, Bertrand
- Abstract
Introduction
- Published
- 2023
- Full Text
- View/download PDF
50. Emergence of Highly-Plastic B Cell States Cooperates with Early Immune Microenvironment Remodeling to Drive Follicular Lymphomagenesis
- Author
-
Brisou, Gabriel, Baaklini, Sabrina, Mossadegh-Keller, Noushin, Beyou, Alicia, Zala, Manon, Gil, Laurine, Soun, Camille, Huber, Caroline, Cervera-Marzal, Iñaki, Bru, Agnés, Potier, Delphine, Gon, Stéphanie, Chasson, Lionel, Antoranz, Asier, Pey Perez, Jon, Gandhi, Anita K., Nakayama, Yumi, Hagner, Patrick R, Milpied, Pierre, Nadel, Bertrand, and Roulland, Sandrine
- Abstract
Follicular lymphoma (FL) is a prototypical example of B cell lymphoma arising from germinal center (GC) B cells. Recent single cell transcriptomic studies investigating the transcriptional heterogeneity of FL suggest that tumor B cells are functionally diverse with cells acquiring an intermediate phenotype between GC and memory (mem), in line with the premalignant FL ontogeny where BCL2 +memory B cells require multiple re-entries into the GC to facilitate the transformation process. Since FL cells often hijack the epigenetic machinery through mutations in histone modifying proteins - notably KMT2D- we questioned here how epigenetic alterations contribute to the emergence of this intratumoral heterogeneity.
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.